Patent · US Active

Composition for use in gene therapy

US8987215B2 · kind B2 · utility

7Cited by

14References

13Claims

0Family size

Assignee

NTNU TECHNOLOGY TRANSFER AS · NO

Inventors

Catherine Taylor · Waterloo, CA
Kurt Ingar Draget · Trondheim, NO

Key dates

Filing date	Mar 23, 2010
Grant date	Mar 24, 2015
Priority date	—
Expiry date	Mar 11, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition useful in gene therapy and a method of treatment to effect gene therapy is provided. In particular, a pharmaceutical composition comprising a nonimmunogenic net polyanionic oligosaccharide, such as an oligouronate, associated with a particulate complex of an anionic nucleic acid material and a cationic macromolecule, optionally together with at least one pharmaceutical carrier or excipient, is provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.